Pros and Cons of Virtual Consulting

by jfrentzen 1/21/2010 12:03:00 PM

The New York Times has posted a well-written article about virtual consulting that touches on the world of plastic surgery. Should Surgeons Meet Patients Online?

Since some family practitioners have begun using electronic visits, the American Academy of Family Physicians has established guidelines, including the stipulation that a physician should evaluate only established patients virtually, and only over “safe, secure, online communication systems.”

The American Society of Plastic Surgeons has no policy. Some plastic surgeons make it clear to their patients that communications through their Web site “are not necessarily secure” and that “you assume the risk of unauthorized use” of say, the topless pictures you send for evaluation.

Read it all.

 

Bioform Exec Profiled in Business Week

by jfrentzen 1/13/2010 1:08:00 PM

Dennis E. Condon, President, Chief Business Officer and Director of BioForm Medical Inc is featured in an Executive Profile in the online pub. Bioform manufactures the Radiesse filler. Dennis Condon: Executive Profile & Biography - BusinessWeek:

Dennis E. Condon has been President and Chief Business Officer of BioForm Medical Inc., since June 2007. Mr. Condon has a strong background in sales, physician education, and direct consumer marketing, and a philosophy of total customer service and support. From March 2006 to June 2007, he served as Chief Executive Officer and President of Apsara Medical. Mr. Condon served as Chief Executive Officer and President of Reliant Technologies Inc. from February 2005 to November ... 2005 and also served as its Executive Vice President. Since November 2002, Mr. Condon has also served as a principal of a privately-held medical aesthetics services practice. He Co-founded and served as Chief Executive Officer and President of the Plastic Surgery Company, from June 1998 to July 2002. His proven leadership record includes 20 years of experience in the aesthetic and medical device marketplace. His broad-based experience with Mentor also includes tenure as Senior Vice President and Vice President of Sales and Marketing (Surgical Products Division) where he had both domestic and international responsibility. In addition, Mr. Condon served as Vice President of International Sales and Marketing at the Heyer-Schulte Division of American Hospital Supply Corporation. He served for 14 years at Mentor Corporation. He served at Mentor Corporation from 1991 to 1998, as Division President of Mentor's Aesthetics Subsidiary.He has been Director of BioForm Medical, Inc. since March 4, 2009.

Etc. etc.

Read it all. The report includes compensation info and industry affiliations.

The Neverending Non Sequitur News Release

by jfrentzen 1/8/2010 7:04:00 AM

Every day, I see news releases that promote a specific plastic or cosmetic surgeon and their specialization or new procedures that they offer. Very often, when I see a news release about, say, a physician whose latest battery of products and services includes fat transfer or infrared treatments, the wording in the release itself follows a tried-and-true pattern:

Dr. XYZ of Your Town USA wants to tell you he is now offering such-and-such new procedure
Such-and-such procedure is...

And then the release launches into a description of the new process or service. Very often, the processes described come straight out of ASPS or ASAPS literature or some well-known published description. Sometimes -- perhaps many times -- there is absolutely nothing new about the process being touted as new. Example in point:

The Gesigner Center, a health care service provider in Pennsylvania, has publshed a news release stating that it has begun to offer a bariatric surgery procedure and that procedure may also "cures diabetes."

"Diabetic patients who undergo bariatric surgery are often cured of diabetes following the procedure," said Christopher Still, D.O., director of the Geisinger Center for Nutrition and Weight Management. "This is an incredible development for patients, as diabetes is often a very challenging condition to manage."

A 2004 study by the Journal of the American Medical Association (JAMA) reported that diabetes was completely resolved for over 76 percent of the 22,000 surveyed patients, and 86 percent of patients saw improvement in their diabetes. In an Annals of Surgery study, 83 percent of diabetic patients were cured after undergoing gastric bypass surgery, the primary bariatric procedure used at Geisinger Medical Center.

The procedure is most effective against type 2 diabetes. It hasn't proven to be a cure against type 1 diabetes, but it can improve a patient's condition, Dr. Still said. By resolving diabetes via surgery, patients are able to avoid medications and insulin injections.

"Many non-surgical treatments for diabetes can be ineffective, expensive and can be difficult for patients to maintain," Dr. Still said. "Bariatric surgery can completely resolve diabetes in one procedure, and sometimes it may be cheaper for a patient to undergo surgery instead of having to purchase medications continually over a number of years."

In order to ensure that patients stay diabetes-free following surgery, Dr. Still stressed that patients must dedicate themselves to maintaining their new body weight.

"Approximately 90 percent of patients diagnosed with type 2 diabetes are obese, and obese people are nearly twice as likely to develop diabetes when compared to someone who is not obese," Dr. Still said. "As a result, patients who fail to maintain their new body weight after bariatric surgery run the risk of re-developing their diabetes."

While the correlation between bariatric surgery and resolving diabetes is clear, research is still being done to determine the reasons why bariatric surgery can act as a diabetes cure, Dr. Still said.

"Studies are being done to investigate a variety of potential explanations, including the way that fat can affect how the body responds to insulin, or how hormones are altered by the procedure," Dr. Still said. "There is no definitive conclusion, but it is clear that the surgery can act as a diabetes cure and can truly help patients enjoy a higher quality of life."

This release starts by saying that Type 2 diabetes can be cured by bariatric surgery, but concludes with a quote from a Gesinger representative doctor that nothing is conclusive. Let us review a smattering of the literature on the subject.

When Should Bariatric Surgery be Used in the Treatment of Type 2 Diabetes?

Gastric Bypass Surgery Explored as Cure for Type 2 Diabetes

Obesity operation may cure diabetes in many

I purposefully chose mainstream news reports in order to show that without ever getting into the technical medical literature, one can find out immediately that although bariatric surgery (especially gastric bypass) may curb Type 2 diabetes in a majority of patients, the process and its results still need more study.

It's alright for Gesinger to promote its new processes and services, but what is the newsorthiness of the annoucement?

I have seen this same syndrome in many, many news reports from all manner of physicians around the country. When you are approving copy for marketing your practice, make sure the facts are correct. While it is tempting to talk about year's-old procedures and "new techniques" that are now being offered by you, make sure your copywriter is accurate about the techniques and their results, as well as claims that may or may not be provable.

 

Authors

Tags

Powered by BlogEngine.NET 1.3.1.0